Home2CL • FRA
add
BridgeBio Pharma Inc
Nakaraang pagsara
€31.78
Sakop ng araw
€33.94 - €34.60
Sakop ng taon
€20.49 - €36.49
Market cap
7.30B USD
Average na Volume
42.00
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | 5.88M | 237.08% |
Gastos sa pagpapatakbo | 225.13M | 26.61% |
Net na kita | -265.05M | -57.63% |
Net profit margin | -4.51K | 53.24% |
Kita sa bawat share | -1.37 | -43.24% |
EBITDA | -219.97M | -25.64% |
Aktuwal na % ng binabayarang buwis | -0.43% | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 681.10M | 56.62% |
Kabuuang asset | 919.34M | 68.26% |
Kabuuang sagutin | 2.38B | 25.84% |
Kabuuang equity | -1.46B | — |
Natitirang share | 190.19M | — |
Presyo para makapag-book | -4.12 | — |
Return on assets | -69.85% | — |
Return on capital | -141.10% | — |
Cash Flow
Net change in cash
| (USD) | Dis 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -265.05M | -57.63% |
Cash mula sa mga operasyon | -195.33M | -56.49% |
Cash mula sa pag-invest | -3.24M | -4,804.55% |
Cash mula sa financing | 473.93M | 10,578.24% |
Net change in cash | 275.37M | 312.79% |
Malayang cash flow | 31.53M | 169.59% |
Tungkol
CEO
Itinatag
2015
Headquarters
Website
Mga Empleyado
728
